Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetics study

Analytical Biochemistry

Volumn 336, Issue 2, 2005, Pages 213-220

  Guo, Wei ^a   Johnson, Jenifer L ^a   Khan, Sumsullah ^a   Ahmad, Ateeq ^a   Ahmad, Imran ^a  

^a I

Author keywords

Bioanalysis; Docetaxel; LC MS MS; Liposome; Paclitaxel

Indexed keywords

LIPOSOMES; LIQUID CHROMATOGRAPHY; LIQUIDS; MAMMALS; MASS SPECTROMETRY; PHARMACOKINETICS; POSITIVE IONS;

BIOANALYSIS; DOCETAXEL; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ASSAYS; MULTIPLE-REACTION MONITORING MODES; PACLITAXEL; TRIPLE-QUADRUPOLE MASS SPECTROMETER;

TISSUE;

DOCETAXEL; LIPOSOME; PACLITAXEL;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TISSUE HOMOGENATE;

EID: 11144283530     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.09.046     Document Type: Article

References (23)

1. E.K. Rowinsky, and R.C. Donehower Paclitaxel (Taxol) N. Engl. J. Med. 332 1995 1004 1014
2. K.S. Price, and M.C. Castells Taxol reactions Allergy Asthma Proc. 23 2002 205 208
3. J. Szebeni, C.R. Alving, S. Savay, Y. Barenholz, A. Priev, D. Danino, and Y. Talmon Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions Int. Immunopharmacol. 1 2001 721 735
4. A. Sparreboom, O. van Tellingen, W.J. Nooijen, and J.H. Beijnen Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL Cancer Res. 56 1996 2112 2115
5. L. Gianni, C.M. Kearns, A. Giani, G. Capri, L. Viganó, A. Locatelli, G. Bonadonna, and M.J. Egorin Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans J. Clin. Oncol. 13 1995 180 190
6. O. van Tellingen, M.T. Huizing, V.R. Panday, J.H. Schellens, W.J. Nooijen, and J.H. Beijnen Cremophor EL causes (pseudo-) nonlinear pharmacokinetics of paclitaxel in patients Br. J. Cancer 81 1999 330 335
7. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
8. P.P. Constantinides, K.J. Lambert, A.K. Tustian, B. Schneider, S. Lalji, W. Ma, B. Wentzel, D. Kessler, D. Worah, and S.C. Quay Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel Pharm. Res. 17 2000 175 182
9. E. Auzenne, N.J. Donato, C. Li, E. Leroux, R.E. Price, D. Farquhar, and J. Kostergaard Superior therapeutic profile of poly-l-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma Clin. Cancer Res. 8 2002 573 581
10. N.K. Ibrahim, N. Desai, S. Legha, P. Soon-Shiong, R.L. Theriault, E. Rivera, B. Esmaeli, S.E. Ring, A. Bedikian, G.N. Horobagyi, and J.A. Ellerhorst Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel Clin. Cancer Res. 8 2002 1038 1044
11. R. Kunstfeld, G. Wickenhauser, U. Michaelis, M. Teifel, W. Umek, K. Naujoks, K. Wolff, and P. Petzelbauer Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model J. Invest. Dermatol. 120 2003 476 482
12. K.J. Harrington, K.N. Syrigos, and R.G. Vile Liposomally targeted cytotoxic drugs for the treatment of cancer J. Pharm. Pharmacol. 54 2002 1573 1600
13. L. Cattel, M. Ceruti, and F. Dosio From conventional to stealth liposomes: a new frontier in cancer chemotherapy Tumori 89 2003 237 249
14. J.A. Zhang, G. Anyarambhatla, L. Ma, S. Ugwu, T. Xuan, T. Sardone, I. Ahmad, Development and characterization formulation of a novel Cremophor free liposome based paclitaxel (LEP-ETU), Eur. J. Pharm. Biopharm. (2005), (in press)
15. S. Ali, S. Lei, A. Pal, N. Kamath, A. Sarkar, S. Sheikh, A. Zhang, I. Ahmad, Enhanced anticancer effects of a novel liposome-based formulation of paclitaxel in human and murine tumor models in mice, Proc. Am. Assoc. Cancer Res. (2nd ed.) 44 (2003)
16. C. Sottani, C. Minoia, M. D'Incalci, M. Paganini, and M. Zucchetti High-performance liquid chromatography tandem mass spectrometry procedure with automated solid phase extraction sample preparation for the quantitative determination of paclitaxel (Taxol) in human plasma Rapid Commun. Mass Spectrom. 12 1998 251 255
17. R.A. Parise, R.K. Ramanathan, W.C. Zamboni, and M.J. Egorin Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 783 2003 231 236
18. G. Basileo, M. Breda, G. Fonte, R. Pisano, and C.A. James Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry J. Pharm. Biomed. Anal. 32 2003 591 600
19. P. Guo, J. Ma, S. Li, and J.M. Gallo Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography-mass spectrometry J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 798 2003 79 86
20. M.S. Alexander, M.M. Kiser, T. Culley, J.R. Kern, J.W. Dolan, J.D. McChesney, J. Zygmunt, and S.J. Bannister Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 785 2003 253 261
21. S.H. Lee, S.D. Yoo, and K.H. Lee Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography J. Chromatogr. B Biomed. Sci. Appl. 724 1999 357 363
22. National Research Council, Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC 1996
23. Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry, "Bioanalytical Method Validation," May 2001, Available from: http://www.fda.gov/cder/guidance/4252fnl.pdf